https://news.medxy.ai/ja/%e6%85%a2%e6%80%a7b%e5%9e%8b%e8%82%9d%e7%82%8e%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e6%8a%97pres1%e6%8a%97%e4%bd%93%e3%81%ae%e6%a9%9f%e8%83%bd%e3%81%a8%e3%82%a6%e3%82%a4%e3%83%ab%e3%82%b9%e5%88%b6/Medxy AIja2026-06-28T21:24:48-07:00慢性B型肝炎における抗preS1抗体の機能とウイルス制御への関与 https://news.medxy.ai/vi/khang-the-anti-pres1-co-hoat-tinh-chuc-nang-va-vai-tro-cua-chung-trong-kiem-soat-vi-rut-o-viem-gan-b-man-tinh/Medxy AIvi2026-06-28T21:24:26-07:00Kháng thể anti-preS1 có hoạt tính chức năng và vai trò của chúng trong kiểm soát vi rút ở viêm gan B mạn tính https://news.medxy.ai/functional-anti-pres1-antibody-responses-and-their-role-in-viral-control-in-chronic-hepatitis-b/Medxy AIen2026-06-28T21:23:12-07:00Functional Anti-preS1 Antibody Responses and Their Role in Viral Control in Chronic Hepatitis B https://news.medxy.ai/left-atrial-to-ventricular-volume-ratio-a-novel-imaging-biomarker-enhancing-detection-of-atrial-cardiopathy-and-stroke-risk/Medxy AIen2026-06-28T20:30:48-07:00Left Atrial to Ventricular Volume Ratio: A Novel Imaging Biomarker Enhancing Detection of Atrial Cardiopathy and Stroke Risk https://news.medxy.ai/incidental-dwi-positive-lesions-as-emerging-biomarkers-in-cerebral-small-vessel-disease-insights-from-caa-and-cadasil-cohorts/Medxy AIen2026-06-28T20:29:37-07:00Incidental DWI-Positive Lesions as Emerging Biomarkers in Cerebral Small Vessel Disease: Insights from CAA and CADASIL Cohorts https://news.medxy.ai/vi/khai-thac-phan-tich-am-hoc-trong-cham-soc-ban-dau-de-phat-hien-suy-giam-nhan-thuc-mot-huong-sang-loc-moi/Medxy AIvi2026-06-28T20:29:02-07:00Khai thác phân tích âm học trong chăm sóc ban đầu để phát hiện suy giảm nhận thức: một hướng sàng lọc mới https://news.medxy.ai/harnessing-acoustic-analysis-in-primary-care-to-detect-cognitive-impairment-a-novel-screening-approach/Medxy AIen2026-06-28T20:28:14-07:00Harnessing Acoustic Analysis in Primary Care to Detect Cognitive Impairment: A Novel Screening Approach https://news.medxy.ai/zh/%e6%99%9a%e6%9c%9f%e7%94%b2%e7%8a%b6%e8%85%ba%e7%99%8c%e6%b2%bb%e7%96%97%e4%b8%ad%e7%9a%84%e7%ba%a2%e7%bb%86%e8%83%9e%e5%a2%9e%e5%a4%9a%e7%97%87%ef%bc%9a%e9%9d%b6%e5%90%91%e8%8d%af%e7%89%a9%e5%bc%95/Medxy AIzh2026-06-28T20:24:37-07:00晚期甲状腺癌治疗中的红细胞增多症：靶向药物引发的新安全性关注 https://news.medxy.ai/ja/%e9%80%b2%e8%a1%8c%e7%94%b2%e7%8a%b6%e8%85%ba%e7%99%8c%e6%b2%bb%e7%99%82%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e8%b5%a4%e8%a1%80%e7%90%83%e5%a2%97%e5%8a%a0%e7%97%87%ef%bc%9a%e5%88%86%e5%ad%90%e6%a8%99/Medxy AIja2026-06-28T20:24:22-07:00進行甲状腺癌治療における赤血球増加症：分子標的薬の新たな安全性課題 https://news.medxy.ai/vi/da-hong-cau-trong-dieu-tri-ung-thu-tuyen-giap-tien-trien-nhung-lo-ngai-an-toan-moi-noi-voi-cac-tac-nhan-nham-trung-dich/Medxy AIvi2026-06-28T20:24:05-07:00Đa hồng cầu trong điều trị ung thư tuyến giáp tiến triển: Những lo ngại an toàn mới nổi với các tác nhân nhắm trúng đích https://news.medxy.ai/erythrocytosis-in-advanced-thyroid-cancer-therapy-emerging-safety-concerns-with-targeted-agents/Medxy AIen2026-06-28T20:23:25-07:00Erythrocytosis in Advanced Thyroid Cancer Therapy: Emerging Safety Concerns with Targeted Agents https://news.medxy.ai/zh/%e5%85%a8%e8%83%b0%e5%88%87%e9%99%a4%e8%81%94%e5%90%88%e8%83%b0%e5%b2%9b%e8%87%aa%e4%bd%93%e7%a7%bb%e6%a4%8d%e5%90%8e%e8%83%b0%e5%b2%9b%e5%8a%9f%e8%83%bd%e4%b8%8e%e8%a1%80%e7%b3%96%e6%8e%a7%e5%88%b6/Medxy AIzh2026-06-28T20:15:51-07:00全胰切除联合胰岛自体移植后胰岛功能与血糖控制的保留：来自连续葡萄糖监测的启示 https://news.medxy.ai/ja/%e8%86%b5%e5%85%a8%e6%91%98%e5%90%8c%e6%99%82%e8%86%b5%e5%b3%b6%e8%87%aa%e5%ae%b6%e7%a7%bb%e6%a4%8d%e5%be%8c%e3%81%ae%e8%86%b5%e5%b3%b6%e6%a9%9f%e8%83%bd%e6%b8%a9%e5%ad%98%e3%81%a8%e8%a1%80%e7%b3%96/Medxy AIja2026-06-28T20:15:35-07:00膵全摘同時膵島自家移植後の膵島機能温存と血糖管理：持続血糖モニタリングからみた知見 https://news.medxy.ai/vi/bao-ton-chuc-nang-tieu-dao-tuy-va-kiem-soat-duong-huyet-sau-cat-toan-bo-tuy-kem-tu-ghep-tieu-dao-tuy-phat-hien-tu-theo-doi-glucose-lien-tuc/Medxy AIvi2026-06-28T20:15:15-07:00Bảo tồn chức năng tiểu đảo tụy và kiểm soát đường huyết sau cắt toàn bộ tụy kèm tự ghép tiểu đảo tụy: phát hiện từ theo dõi glucose liên tục https://news.medxy.ai/preservation-of-islet-function-and-glycaemic-control-after-total-pancreatectomy-with-islet-autotransplantation-insights-from-continuous-glucose-monitoring/Medxy AIen2026-06-28T20:14:37-07:00Preservation of Islet Function and Glycaemic Control After Total Pancreatectomy with Islet Autotransplantation: Insights From Continuous Glucose Monitoring https://news.medxy.ai/personalizing-osteoporosis-treatment-integrating-pharmacotherapy-with-patient-centered-lifestyle-strategies/Medxy AIen2026-06-28T18:42:06-07:00Personalizing Osteoporosis Treatment: Integrating Pharmacotherapy with Patient-Centered Lifestyle Strategies https://news.medxy.ai/zh/%e5%80%9f%e5%8a%a9-pepper-%e6%8f%90%e5%8d%87%e9%9d%92%e5%b0%91%e5%b9%b4%e9%85%ae%e7%97%87%e5%80%be%e5%90%91%e6%80%a7%e7%b3%96%e5%b0%bf%e7%97%85%e8%af%86%e5%88%ab%e6%95%88%e7%8e%87%ef%bc%9a%e6%8e%a8/Medxy AIzh2026-06-28T18:14:51-07:00借助 PEPPER 提升青少年酮症倾向性糖尿病识别效率：推动非典型糖尿病发现 https://news.medxy.ai/ja/pepper%e3%81%a7%e8%8b%a5%e5%b9%b4%e8%80%85%e3%81%ae%e3%82%b1%e3%83%88%e3%83%bc%e3%82%b7%e3%82%b9%e5%82%be%e5%90%91%e7%b3%96%e5%b0%bf%e7%97%85%e3%82%92%e8%bf%85%e9%80%9f%e5%90%8c%e5%ae%9a%ef%bc%9a/Medxy AIja2026-06-28T18:14:36-07:00PEPPERで若年者のケトーシス傾向糖尿病を迅速同定：非典型糖尿病発見を加速する https://news.medxy.ai/vi/rut-ngan-phat-hien-dai-thao-duong-nhiem-toan-ceton-o-thanh-thieu-nien-bang-pepper-thuc-day-nhan-dien-dai-thao-duong-khong-dien-hinh/Medxy AIvi2026-06-28T18:14:18-07:00Rút ngắn phát hiện đái tháo đường nhiễm toan ceton ở thanh thiếu niên bằng PEPPER: thúc đẩy nhận diện đái tháo đường không điển hình https://news.medxy.ai/streamlining-identification-of-ketosis-prone-diabetes-in-youth-using-pepper-advancing-atypical-diabetes-discovery/Medxy AIen2026-06-28T18:13:43-07:00Streamlining Identification of Ketosis-Prone Diabetes in Youth Using PEPPER: Advancing Atypical Diabetes Discovery https://news.medxy.ai/vi/aficamten-hay-metoprolol-dau-la-lua-chon-uu-viet-hon-trong-benh-co-tim-phi-dai-tac-nghen-du-lieu-tu-thu-nghiem-ngau-nhien-pha-3-maple-hcm/Medxy AIvi2026-06-28T09:36:41-07:00Aficamten hay metoprolol: đâu là lựa chọn ưu việt hơn trong bệnh cơ tim phì đại tắc nghẽn? Dữ liệu từ thử nghiệm ngẫu nhiên pha 3 MAPLE-HCM https://news.medxy.ai/exercise-performance-with-aficamten-vs-metoprolol-in-obstructive-hypertrophic-cardiomyopathy-insights-from-the-maple-hcm-phase-3-randomized-trial/Medxy AIen2026-06-28T09:35:15-07:00Exercise Performance With Aficamten vs Metoprolol in Obstructive Hypertrophic Cardiomyopathy: Insights from the MAPLE-HCM Phase 3 Randomized Trial https://news.medxy.ai/vi/aficamten-cho-thay-loi-ich-ben-vung-va-tinh-an-toan-trong-quan-ly-dai-han-benh-co-tim-phi-dai-tac-nghen-co-trieu-chung-nhung-phat-hien-tu-nghien-cuu-forest-hcm/Medxy AIvi2026-06-28T09:01:47-07:00Aficamten cho thấy lợi ích bền vững và tính an toàn trong quản lý dài hạn bệnh cơ tim phì đại tắc nghẽn có triệu chứng: Những phát hiện từ nghiên cứu FOREST-HCM https://news.medxy.ai/aficamten-demonstrates-sustained-benefits-and-safety-in-long-term-management-of-symptomatic-obstructive-hypertrophic-cardiomyopathy-insights-from-the-forest-hcm-study/Medxy AIen2026-06-28T09:00:17-07:00Aficamten Demonstrates Sustained Benefits and Safety in Long-Term Management of Symptomatic Obstructive Hypertrophic Cardiomyopathy: Insights from the FOREST-HCM Study https://news.medxy.ai/long-term-success-of-combined-myectomy-and-secondary-mitral-chordal-cutting-in-obstructive-hypertrophic-cardiomyopathy/Medxy AIen2026-06-28T08:39:37-07:00Long-Term Success of Combined Myectomy and Secondary Mitral Chordal Cutting in Obstructive Hypertrophic Cardiomyopathy https://news.medxy.ai/vi/ket-cuc-dai-han-va-dong-hoc-ctdna-o-ung-thu-vu-duong-tinh-erbb2-giai-doan-som-dieu-tri-bang-paclitaxel-trastuzumab-va-pertuzumab-tien-phau-ket-qua-tu-thu-nghiem-daphne/Medxy AIvi2026-06-28T08:02:33-07:00Kết cục dài hạn và động học ctDNA ở ung thư vú dương tính ERBB2 giai đoạn sớm điều trị bằng paclitaxel, trastuzumab và pertuzumab tiền phẫu: Kết quả từ thử nghiệm DAPHNe https://news.medxy.ai/long-term-efficacy-and-ctdna-dynamics-in-early-stage-erbb2-positive-breast-cancer-treated-with-neoadjuvant-paclitaxel-trastuzumab-and-pertuzumab-insights-from-the-daphne-trial/Medxy AIen2026-06-28T08:00:49-07:00Long-Term Efficacy and ctDNA Dynamics in Early-Stage ERBB2-Positive Breast Cancer Treated with Neoadjuvant Paclitaxel, Trastuzumab, and Pertuzumab: Insights from the DAPHNe Trial https://news.medxy.ai/zh/%e8%bf%9c%e7%a8%8b%e5%8c%bb%e7%96%97%e9%98%b6%e6%a2%af%e5%bc%8f%e9%85%92%e7%b2%be%e6%b2%bb%e7%96%97%e8%83%bd%e5%90%a6%e5%b8%ae%e5%8a%a9%e6%85%a2%e6%80%a7%e8%82%9d%e7%97%85%e6%82%a3%e8%80%85%e5%87%8f/Medxy AIzh2026-06-27T21:39:57-07:00远程医疗阶梯式酒精治疗能否帮助慢性肝病患者减酒？一项2026年随机对照试验的启示 https://news.medxy.ai/ja/%e6%85%a2%e6%80%a7%e8%82%9d%e7%96%be%e6%82%a3%e3%81%ab%e3%81%8a%e3%81%91%e3%82%8b%e9%81%a0%e9%9a%94%e5%8c%bb%e7%99%82%e5%9e%8b%e6%ae%b5%e9%9a%8e%e7%9a%84%e3%82%a2%e3%83%ab%e3%82%b3%e3%83%bc%e3%83%ab/Medxy AIja2026-06-27T21:39:37-07:00慢性肝疾患における遠隔医療型段階的アルコール治療の評価：2026年無作為化比較試験からの知見 https://news.medxy.ai/vi/telehealth-dieu-tri-ruou-theo-bac-o-benh-gan-man-tinh-goi-y-tu-mot-thu-nghiem-ngau-nhien-nam-2026/Medxy AIvi2026-06-27T21:39:10-07:00Telehealth điều trị rượu theo bậc ở bệnh gan mạn tính: Gợi ý từ một thử nghiệm ngẫu nhiên năm 2026 https://news.medxy.ai/evaluating-telehealth-stepped-alcohol-treatment-to-reduce-alcohol-use-in-chronic-liver-disease-insights-from-a-2026-randomized-controlled-trial/Medxy AIen2026-06-27T21:38:13-07:00Evaluating Telehealth Stepped Alcohol Treatment to Reduce Alcohol Use in Chronic Liver Disease: Insights from a 2026 Randomized Controlled Trial https://news.medxy.ai/zh/%e9%9d%b6%e5%90%91nek9%e9%87%8d%e5%a1%91%e8%82%bf%e7%98%a4%e5%be%ae%e7%8e%af%e5%a2%83%ef%bc%9a%e5%85%8b%e6%9c%8d%e8%82%9d%e7%bb%86%e8%83%9e%e7%99%8c%e5%85%8d%e7%96%ab%e6%b2%bb%e7%96%97%e8%80%90/Medxy AIzh2026-06-27T20:45:59-07:00靶向NEK9重塑肿瘤微环境：克服肝细胞癌免疫治疗耐药的新策略 https://news.medxy.ai/ja/%e8%82%9d%e7%b4%b0%e8%83%9e%e7%99%8c%e3%81%ae%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e6%8a%b5%e6%8a%97%e6%80%a7%e3%82%92nek9%e6%a8%99%e7%9a%84%e5%8c%96%e3%81%a7%e5%85%8b%e6%9c%8d%e3%81%99%e3%82%8b/Medxy AIja2026-06-27T20:45:44-07:00肝細胞癌の免疫療法抵抗性をNEK9標的化で克服する：腫瘍微小環境の再プログラム化による新戦略 https://news.medxy.ai/vi/nham-dich-nek9-de-vuot-qua-khang-lieu-phap-mien-dich-trong-ung-thu-bieu-mo-te-bao-gan-bang-cach-tai-lap-trinh-vi-moi-truong-khoi-u/Medxy AIvi2026-06-27T20:45:25-07:00Nhắm đích NEK9 để vượt qua kháng liệu pháp miễn dịch trong ung thư biểu mô tế bào gan bằng cách tái lập trình vi môi trường khối u https://news.medxy.ai/targeting-nek9-to-overcome-immunotherapy-resistance-in-hepatocellular-carcinoma-by-reprogramming-the-tumor-microenvironment/Medxy AIen2026-06-27T20:44:39-07:00Targeting NEK9 to Overcome Immunotherapy Resistance in Hepatocellular Carcinoma by Reprogramming the Tumor Microenvironment https://news.medxy.ai/birc3-gene-variants-disrupt-ripk1-signaling-driving-monogenic-crohns-disease-new-insights-and-therapeutic-avenues/Medxy AIen2026-06-27T20:43:19-07:00BIRC3 Gene Variants Disrupt RIPK1 Signaling, Driving Monogenic Crohn’s Disease: New Insights and Therapeutic Avenues https://news.medxy.ai/vi/tai-thong-mach-mau-thanh-cong-giup-cai-thien-hoi-phuc-chuc-nang-trong-dot-quy-thieu-mau-cuc-bo-nhe-phan-tich-tu-thu-nghiem-tempo-2/Medxy AIvi2026-06-27T20:42:22-07:00Tái thông mạch máu thành công giúp cải thiện hồi phục chức năng trong đột quỵ thiếu máu cục bộ nhẹ: Phân tích từ thử nghiệm TEMPO-2 https://news.medxy.ai/successful-recanalization-boosts-functional-recovery-in-minor-ischemic-stroke-insights-from-the-tempo-2-trial/Medxy AIen2026-06-27T20:41:21-07:00Successful Recanalization Boosts Functional Recovery in Minor Ischemic Stroke: Insights from the TEMPO-2 Trial https://news.medxy.ai/vi/cac-phan-%d1%82%d0%b8%d0%bf-phu-nao-som-khac-biet-co-du-bao-ket-cuc-trong-huyet-khoi-tinh-mach-nao-phan-tich-tu-so-dang-ky-clot-venus/Medxy AIvi2026-06-27T20:40:39-07:00Các phân тип phù não sớm khác biệt có dự báo kết cục trong huyết khối tĩnh mạch não: Phân tích từ sổ đăng ký CLOT-VENUS https://news.medxy.ai/distinct-early-cerebral-edema-subtypes-as-predictors-of-outcome-in-cerebral-venous-thrombosis-insights-from-the-clot-venus-registry/Medxy AIen2026-06-27T20:39:54-07:00Distinct Early Cerebral Edema Subtypes as Predictors of Outcome in Cerebral Venous Thrombosis: Insights from the CLOT-VENUS Registry https://news.medxy.ai/vi/y-nghia-lam-sang-cua-tmem106b-trong-dich-nao-tuy-o-sa-sut-tri-tue-tran-thai-duong-di-truyen-va-rai-rac-tong-quan-tich-hop/Medxy AIvi2026-06-27T11:58:40-07:00Ý nghĩa lâm sàng của TMEM106B trong dịch não tủy ở sa sút trí tuệ trán–thái dương di truyền và rải rác: tổng quan tích hợp https://news.medxy.ai/clinical-associations-of-cerebrospinal-fluid-tmem106b-in-familial-and-sporadic-frontotemporal-dementia-an-integrative-review/Medxy AIen2026-06-27T11:57:49-07:00Clinical Associations of Cerebrospinal Fluid TMEM106B in Familial and Sporadic Frontotemporal Dementia: An Integrative Review https://news.medxy.ai/ja/%e5%b0%8f%e5%85%90%e7%94%b2%e7%8a%b6%e8%85%ba%e6%a9%9f%e8%83%bd%e4%ba%a2%e9%80%b2%e7%97%87%e3%81%ae%e6%b2%bb%e7%99%82%e3%81%af%e3%81%a9%e3%81%86%e5%a4%89%e3%82%8f%e3%81%a3%e3%81%9f%e3%81%8b%ef%bc%9a20/Medxy AIja2026-06-27T11:56:46-07:00小児甲状腺機能亢進症の治療はどう変わったか：20年にわたる管理と転帰の総説 https://news.medxy.ai/vi/cuong-giap-o-tre-em-su-thay-doi-trong-chien-luoc-dieu-tri-va-ket-cuc-qua-hai-thap-ky/Medxy AIvi2026-06-27T11:56:19-07:00Cường giáp ở trẻ em: sự thay đổi trong chiến lược điều trị và kết cục qua hai thập kỷ https://news.medxy.ai/evolving-paradigms-in-pediatric-hyperthyroidism-a-two-decade-review-of-management-and-outcomes/Medxy AIen2026-06-27T11:55:16-07:00Evolving Paradigms in Pediatric Hyperthyroidism: A Two-Decade Review of Management and Outcomes https://news.medxy.ai/zh/%e5%88%a9%e6%8b%89%e9%b2%81%e8%82%bd%e5%a2%9e%e5%bc%ba%e8%83%b0%e5%b2%9b%e7%b4%a0%e5%88%86%e6%b3%8c%e4%b8%8e%e6%8e%a7%e7%b3%96%e4%bd%9c%e7%94%a8%e7%9a%84%e4%bb%a3%e8%b0%a2%e7%8a%b6%e6%80%81%e4%be%9d/Medxy AIzh2026-06-27T11:08:32-07:00利拉鲁肽增强胰岛素分泌与控糖作用的代谢状态依赖性机制 https://news.medxy.ai/ja/%e4%bb%a3%e8%ac%9d%e7%8a%b6%e6%85%8b%e3%81%a7%e5%a4%89%e3%82%8f%e3%82%8b-liraglutide-%e3%81%ae%e4%bd%9c%e7%94%a8%e6%a9%9f%e5%ba%8f%ef%bc%9a%e3%82%a4%e3%83%b3%e3%82%b9%e3%83%aa%e3%83%b3%e5%88%86/Medxy AIja2026-06-27T11:08:18-07:00代謝状態で変わる liraglutide の作用機序：インスリン分泌と血糖調節をどう高めるか https://news.medxy.ai/vi/liraglutide-tang-bai-tiet-insulin-va-kiem-soat-duong-huyet-theo-tung-trang-thai-chuyen-hoa/Medxy AIvi2026-06-27T11:08:02-07:00Liraglutide tăng bài tiết insulin và kiểm soát đường huyết theo từng trạng thái chuyển hóa https://news.medxy.ai/metabolic-state-dependent-mechanisms-of-liraglutide-in-enhancing-insulin-secretion-and-glycemic-control/Medxy AIen2026-06-27T11:07:19-07:00Metabolic State-Dependent Mechanisms of Liraglutide in Enhancing Insulin Secretion and Glycemic Control https://news.medxy.ai/zh/%e5%8f%b8%e7%be%8e%e6%a0%bc%e9%b2%81%e8%82%bd%e7%94%a8%e4%ba%8e%e6%88%90%e4%ba%ba%e9%9a%90%e5%8c%bf%e6%80%a7%e8%87%aa%e8%ba%ab%e5%85%8d%e7%96%ab%e6%80%a7%e7%b3%96%e5%b0%bf%e7%97%85%e7%9a%84%e6%9c%89/Medxy AIzh2026-06-27T10:47:34-07:00司美格鲁肽用于成人隐匿性自身免疫性糖尿病的有效加用治疗：改善血糖控制并保留β细胞功能 https://news.medxy.ai/ja/lada%e3%81%ab%e5%af%be%e3%81%99%e3%82%8b%e3%82%bb%e3%83%9e%e3%82%b0%e3%83%ab%e3%83%81%e3%83%89%e8%bf%bd%e5%8a%a0%e7%99%82%e6%b3%95%e3%81%ae%e5%8f%af%e8%83%bd%e6%80%a7%ef%bc%9a%e8%a1%80%e7%b3%96/Medxy AIja2026-06-27T10:47:21-07:00LADAに対するセマグルチド追加療法の可能性：血糖管理の改善とβ細胞機能温存 https://news.medxy.ai/vi/semaglutide-nhu-lieu-phap-bo-tro-hieu-qua-trong-dai-thao-duong-tu-mien-tiem-an-o-nguoi-lon-cai-thien-kiem-soat-duong-huyet-va-bao-ton-chuc-nang-te-bao-%ce%b2/Medxy AIvi2026-06-27T10:47:04-07:00Semaglutide như liệu pháp bổ trợ hiệu quả trong đái tháo đường tự miễn tiềm ẩn ở người lớn: cải thiện kiểm soát đường huyết và bảo tồn chức năng tế bào β https://news.medxy.ai/semaglutide-as-an-effective-add-on-therapy-in-latent-autoimmune-diabetes-in-adults-enhancing-glycemic-control-and-preserving-%ce%b2-cell-function/Medxy AIen2026-06-27T10:46:22-07:00Semaglutide as an Effective Add-On Therapy in Latent Autoimmune Diabetes in Adults: Enhancing Glycemic Control and Preserving β-Cell Function https://news.medxy.ai/zh/%e8%9b%8b%e7%99%bd%e8%b4%a8%e7%bb%84%e5%ad%a6%e6%a0%87%e5%bf%97%e7%89%a9%e5%8f%af%e9%a2%84%e6%b5%8b%e7%a9%ba%e8%85%b9%e8%a1%80%e7%b3%96%e5%8f%97%e6%8d%9f%e5%90%91%e7%b3%96%e5%b0%bf%e7%97%85%e7%9a%84/Medxy AIzh2026-06-27T09:12:27-07:00蛋白质组学标志物可预测空腹血糖受损向糖尿病的进展：ARIC研究带来的启示 https://news.medxy.ai/ja/%e7%a9%ba%e8%85%b9%e6%99%82%e8%a1%80%e7%b3%96%e7%95%b0%e5%b8%b8%e3%81%8b%e3%82%89%e7%b3%96%e5%b0%bf%e7%97%85%e3%81%b8%e3%81%ae%e9%80%b2%e5%b1%95%e3%82%92%e4%ba%88%e6%b8%ac%e3%81%99%e3%82%8b%e3%83%97/Medxy AIja2026-06-27T09:12:11-07:00空腹時血糖異常から糖尿病への進展を予測するプロテオームマーカー：ARIC研究からの知見 https://news.medxy.ai/vi/dau-an-proteomics-du-doan-su-tien-trien-tu-roi-loan-duong-huyet-luc-doi-sang-dai-thao-duong-goc-nhin-tu-nghien-cuu-aric/Medxy AIvi2026-06-27T09:11:52-07:00Dấu ấn proteomics dự đoán sự tiến triển từ rối loạn đường huyết lúc đói sang đái tháo đường: Góc nhìn từ nghiên cứu ARIC https://news.medxy.ai/proteomic-markers-predicting-progression-from-impaired-fasting-glucose-to-diabetes-insights-from-the-aric-study/Medxy AIen2026-06-27T09:10:31-07:00Proteomic Markers Predicting Progression from Impaired Fasting Glucose to Diabetes: Insights from the ARIC Study https://news.medxy.ai/zh/%e8%8b%b1%e6%a0%bc%e5%85%b0%e8%82%a5%e8%83%96%e4%b8%8e%e5%81%a5%e5%ba%b7%e4%b8%8d%e5%b9%b3%e7%ad%89%e7%9a%84%e5%85%a8%e4%ba%ba%e7%be%a4%e8%b6%8b%e5%8a%bf%ef%bc%882019-2025%ef%bc%89%ef%bc%9a/Medxy AIzh2026-06-27T09:07:24-07:00英格兰肥胖与健康不平等的全人群趋势（2019—2025）：基于5400万成人队列的研究洞见 https://news.medxy.ai/ja/%e3%82%a4%e3%83%b3%e3%82%b0%e3%83%a9%e3%83%b3%e3%83%895400%e4%b8%87%e4%ba%ba%e3%82%b3%e3%83%9b%e3%83%bc%e3%83%88%e3%81%8c%e7%a4%ba%e3%81%99%e8%82%a5%e6%ba%80%e3%81%a8%e6%a0%bc%e5%b7%ae%e3%81%ae/Medxy AIja2026-06-27T09:07:04-07:00イングランド5400万人コホートが示す肥満と格差の全体像：2019～2025年の推移 https://news.medxy.ai/vi/xu-huong-beo-phi-toan-dan-va-bat-binh-dang-tai-anh-2019-2025-phan-tich-tu-doan-he-54-trieu-nguoi-truong-thanh/Medxy AIvi2026-06-27T09:06:44-07:00Xu hướng béo phì toàn dân và bất bình đẳng tại Anh, 2019–2025: Phân tích từ đoàn hệ 54 triệu người trưởng thành https://news.medxy.ai/whole-population-trends-in-obesity-and-inequality-in-england-2019-2025-insights-from-a-cohort-of-54-million-adults/Medxy AIen2026-06-27T09:04:56-07:00Whole-Population Trends in Obesity and Inequality in England, 2019-2025: Insights from a Cohort of 54 Million Adults https://news.medxy.ai/zh/%e7%82%8e%e7%97%87%e5%a6%82%e4%bd%95%e4%bf%ae%e9%a5%b0%e8%84%82%e8%9b%8b%e7%99%bda%e7%9b%b8%e5%85%b3%e5%bf%83%e8%a1%80%e7%ae%a1%e9%a3%8e%e9%99%a9%ef%bc%9a%e6%9d%a5%e8%87%aa-uk-biobank-%e7%9a%84/Medxy AIzh2026-06-27T08:56:43-07:00炎症如何修饰脂蛋白(a)相关心血管风险：来自 UK Biobank 的研究启示 https://news.medxy.ai/ja/%e7%82%8e%e7%97%87%e3%81%aflipoproteina%e9%96%a2%e9%80%a3%e5%bf%83%e8%a1%80%e7%ae%a1%e3%83%aa%e3%82%b9%e3%82%af%e3%82%92%e3%81%a9%e3%81%86%e4%bf%ae%e9%a3%be%e3%81%99%e3%82%8b%e3%81%ae%e3%81%8b/Medxy AIja2026-06-27T08:56:23-07:00炎症はLipoprotein(a)関連心血管リスクをどう修飾するのか：UK Biobankからの知見 https://news.medxy.ai/vi/viem-lam-thay-doi-nguy-co-tim-mach-lien-quan-den-lipoproteina-phan-tich-tu-uk-biobank/Medxy AIvi2026-06-27T08:56:01-07:00Viêm làm thay đổi nguy cơ tim mạch liên quan đến Lipoprotein(a): Phân tích từ UK Biobank https://news.medxy.ai/inflammation-as-a-modifier-of-lipoproteina-associated-cardiovascular-risk-insights-from-the-uk-biobank/Medxy AIen2026-06-27T08:54:54-07:00Inflammation as a Modifier of Lipoprotein(a)–Associated Cardiovascular Risk: Insights from the UK Biobank